Tech Company Financing Transactions
Inversago Pharma Funding Round
On 10/17/2022, Inversago Pharma raised $69 million in Series C financing from New Enterprise Associates, adMare BioInnovations and Amgen Ventures.
Transaction Overview
New Enterprise Associates (Lead Investor)
AmorChem (Elizabeth Douville)
Forbion Capital Partners (Marco Boorsma)
Genesys Capital (Jamie Stiff)
JDRF T1D Fund (Jonathan Behr)
Company Information
Montreal QC, H3B 2B6
Canada
Management Team
Browse more venture capital transactions:
Prev: 10/17/2022: Mobility Work venture capital transaction
Next: 10/17/2022: Surge Therapeutics venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs